News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Sanofi-Aventis (France), Daiichi Sankyo Co Ltd. Delay Japan’s First Imported Vaccine
October 1, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Sept. 30 (Bloomberg) -- Sanofi-Aventis SA and Daiichi Sankyo Co. delayed plans to sell the first imported vaccine in Japan because it's taking longer than expected to make the product meet the country's standards.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
Asia
Sanofi (France)
Daiichi Sankyo
MORE ON THIS TOPIC
Approvals
Ascendis Enters Achondroplasia Arena as FDA Approves First Weekly Drug
March 2, 2026
·
2 min read
·
Tristan Manalac
CDC
RFK Jr. Appoints 2 New Advisors to CDC Vaccine Panel Ahead of March Meeting
March 2, 2026
·
2 min read
·
Tristan Manalac
Regulatory
FDA Action Alert: BMS, GSK, Aldeyra and More
March 2, 2026
·
4 min read
·
Tristan Manalac
FDA
FDA To Offer Bonus Payments for Speedy Drug Reviewers
February 27, 2026
·
1 min read
·
Annalee Armstrong